10 April 2026
Have your say
Proposed 2026–27 fees and charges
We’re seeking your feedback on proposed AICIS fees and charges for the 2026–27 registration year (1 September 2026 to 31 August 2027). The proposals aim to support the long‑term financial sustainability of our scheme and comply with the Australian Government Cost Recovery Policy.
Key proposals:
- One‑off 90% discount to the 2026–27 registration levy (to reduce unplanned surplus funds in our cash reserve) and reinstate the pre-2026–27 levy charge in 2027–28, including deferred indexation.
- Simplify certificate applications by reducing application types from 5 to 3 and increase fees to recover the full cost of processing and assessing applications.
- Apply indexation only to other fees for services, with no changes to their structure.
Open for comment until Friday 15 May 2026.
Draft evaluations open for public comment
We welcome your comments on our latest draft evaluations. Three of these evaluations propose regulatory changes to the Inventory terms of listing for these chemicals:
- Retinol and retinol esters (EVA00187)
- 2‑Pyrrolidinone (EVA00193)
- Methanone, [1,1'-biphenyl]-4-ylphenyl- (4-Phenylbenzophenone) (EVA00201)
Open for comment until Thursday 28 May 2026.
Inventory notices
Inventory variation notice: revoked CBI and updates to terms of listing on specific information requirements
CAS number: 2097886-94-5
Chemical added to the Inventory 5 years after issue of assessment certificate
CAS number: 133222-51-2
AICIS is officially on LinkedIn!
Our LinkedIn page is another way we'll share timely, helpful information with you.
Follow us and stay up to date with:
- regulatory updates
- tips and guidance
- reminders about key dates and deadlines.
